Matrix metalloproteinases in a gerbil cholesteatoma model

Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 4, 2003, Pages 402-407

  Wilmoth, Jason G ^a   Schultz, Gregory S ^a   Antonelli, Patrick J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATELECTASIS; AUDITORY TUBE DYSFUNCTION; CHOLESTEATOMA; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; GERBIL; LAMINA PROPRIA; MEDIATOR RELEASE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

EID: 0141923709     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0194-5998(03)01317-2     Document Type: Article

References (25)

1. Monsell EM, Harley RE. Eustachian tube dysfunction. Otolaryngol Clin North Am 1996;29:437-44.
2. Yoon TH, Schachern PA, Paparella MM, et al. Pathology and pathogenesis of tympanic membrane retraction. Am J Otolaryngol 1990;11:10-17.
3. Bluestone CD, Klein JO. Otitis media, atelectasis, and Eustachian tube dysfunction. In: Bluestone CD, Stool SE, Kenna MA, editors. Pediatric otolaryngology, Vol 1. Philadelphia: WB Saunders; 1996. p. 388-582.
4. Sade J, Berco E. Atelectasis and secretory otitis media. Ann Otol Rhinol Laryngol 1976;85(Suppl 25):55-72.
5. Wolfman DE, Chole RA. Experimental retraction pocket cholesteatoma. Ann Otol Rhinol Laryngol 1986;95:639-44.
6. Kim H, Chole RA. Experimental models of aural cholesteatomas in Mongolian gerbils. Ann Otol Rhinol Laryngol 1998;107:129-34.
7. Masaki M, Wright CG, Lee DH, et al. Experimental cholesteatoma. Epidermal ingrowth through tympanic membrane following middle ear application of propylene glycol. Acta Otolaryngol 1989;108:113-21.
8. Huang CC, Shi GS, Yi ZX. Experimental induction of middle ear cholesteatoma in rats. Am J Otolaryngol 1988;9:165-72.
9. Schmidt SH, Hellstrom S. Experimental cholesteatoma in the rat. Acta Otolaryngol 1994;114:430-4.
10. Friedmann I. The comparative pathology of otitis media-experimental and human, II. The histopathology of experimental otitis of the guinea pig with particular reference to cholesteatoma. J Laryngol Otol 1955;69:588-601.
11. Meyerhoff WL, Wright CG, Gerken GM. Effects of middle ear ventilation on cholesteatoma development in experimental animals. Acta Otolaryngol 1990;110:279-85.
12. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993;101:64-68.
13. Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Rep Reg 1996;4:411-20.
14. McCulloch CAG. Colagenolytic enzymes in gingival crevicular fluid as diagnostic indicators of peridontitis. Ann NY Acad Sci 1994;732:152-64.
15. Krane SM. Mechanisms of tissue destruction in rheumatoid arthritis. In: McCarty DJ, Koopman WJ, editors. Arthritis and allied conditions: a textbook in rheumatology, 12th ed. Philadelphia: Lea and Febiger; 1993. p. 763-69.
16. Schonermark M, Mester B, Kempf H, et al. Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol 1996;116:451-6.
17. Yan S, Huang C. Tumor necrosis factor alpha in middle ear cholesteatoma and its effects on keratinocytes in vitro. Ann Otol Rhinol Laryngol 1991;100:157-61.
18. Yan S, Huang C. The role of tumor necrosis factor-alpha in bone resorption of cholesteatoma. Am J Otolaryngol 1991;12:83-9.
19. Gaines GC, Welborn MB III, Moldawer LL, et al. Attenuation of skeletal muscle ischemia/reperfusion injury by inhibition of tumor necrosis factor. J Vasc Surg 1999;29:370-6.
20. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 1994;218:325-9.
21. Krane SM. Clinical importance of metalloproteinases and their inhibitors. Ann N Y Acad Sci 1994;732:1-10.
22. Stetler-Stevenson WG, Liotta LA, Kleiner DE. Extracellular matrix 6: role of matrix metalloproteases in tumor invasion and metastasis. FASEB J 1993;7:1434-41.
23. Casselbrandt ML, Cantekin EI, Dirkmaat DC, et al. Experimental paralysis of tensor veli palatini muscle. Acta Otolaryngol (Stockh) 1988;106:178-85.
24. Rayner MG, Zhang Y, Gorry MC, et al. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA 1998;279:296-9.
25. Goycoolea MV, Paparella MM, Carpenter AM, et al. A longitudinal study of cellular changes in experimental otitis media. Otolaryngol Head Neck Surg 1979;87:685-700.